(157 days)
No
The document describes a traditional image-guided navigation system using optical tracking and image registration, with no mention of AI or ML in the device description, intended use, or performance studies.
No.
The device is a navigation and guidance system used for precise positioning of surgical instruments or implants during spine surgery, not a device that directly treats a disease or condition.
No
The device is described as a "planning and intraoperative guidance system" for surgery, which tracks instruments and displays their position on images, rather than diagnosing a condition.
No
The device description explicitly states that the system is comprised of a platform, clinical software, surgical instruments, and a referencing system, and that the modified system includes software, hardware, and instrument modifications. This indicates it is not solely software.
Based on the provided information, the Anatase Spine Surgery Navigation System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- Anatase System's Function: The Anatase system is a surgical navigation system. Its purpose is to provide guidance and precise positioning of surgical instruments and implants during surgery, based on medical images. It does not analyze biological specimens.
- Intended Use: The intended use clearly states its role in "precise positioning of surgical instruments or spinal implants during general spinal surgery" and as a "planning and intraoperative guidance system." This is a surgical aid, not a diagnostic tool that analyzes samples.
Therefore, the Anatase Spine Surgery Navigation System falls under the category of surgical navigation or image-guided surgery systems, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The Anatase Spine Surgery Navigation System is indicated for precise positioning of surgical instruments or spinal implants during general spinal surgery when reference to a rigid anatomical structure, such as the vertebra, can be identified relative to a patient's fluoroscopic or CT imagery. It is intended as a planning and intraoperative guidance system to enable open or percutaneous image guided surgery by means of registering intraoperative 2D fluoroscopic projections to pre-operative 3D CT imagery.
Example procedures include but are not limited to: Posterior-approach spinal implant procedures, such as pedicle screw placement, within the lumbar region.
Product codes (comma separated list FDA assigned to the subject device)
OLO
Device Description
The Anatase Spine Surgery Navigation System, also known as an Image Guided System, is comprised of a platform, clinical software, surgical instruments, and a referencing system. The system uses optical tracking technology to track the position of instruments in relation to the surgical anatomy and identifies this position on diagnostic or intraoperative images of a patient. The system helps guide surgeons during spine procedures such as spinal fusion. The software functionality in terms of its feature sets is categorized as imaging modalities, registration, planning, interfaces with medical devices, and views.
The modified Anatase Spine Surgery Navigation System, the subject of these 510(k) applications, introduces software, hardware and instruments modifications to the original Surgery Navigation System cleared in 510(k) K180523.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
fluoroscopic or CT imagery, intraoperative 2D fluoroscopic projections, pre-operative 3D CT imagery
Anatomical Site
vertebra, lumbar region (spine)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
surgeons (operating room/clinical setting)
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-Clinical Testing:
- Sterilization: Moist heat sterilization of those reusable accessories is validated in accordance with ISO 17665-1:2006.
- Repeated Reprocessing: Reliability of those reusable instruments after repeated reprocessing is validated throughout their use-life, for reference of ISO 11737-2: 2019.
- Biocompatibility: Biocompatibility of those accessories that come into contact with patient is evaluated in accordance with FDA guidance for the use of international standard ISO 10993-1, "Biological evaluation of medical devices – Part 1: Evaluation and testing within a risk management process" issued on June 16, 2016 and ISO 10993-1:2009.
- Software: Software is verified and validated in accordance with FDA guidance for the content of premarket submissions for software contained in medical devices issued on May 11, 2005.
- Electrical Safety: Electrical safety of the system is complied with the requirements of ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012, C1:2009/(R)2012 and A2:2010/(R)2012.
- Electromagnetic Compatibility: Electromagnetic compatibility of the system is complied with the requirements of IEC 60601-1-2:2014.
- Usability: Usability of the system is validated in accordance with ANSI/AAMI HE75:2009/(R)2013, IEC 62366-1:2015 and IEC 60601-1-6:2010 + A1:2013.
- Accuracy: Positional accuracy of the system is evaluated in accordance with ASTM F2554-18.
- Risk Assessment: The effectiveness of all risk control measures is verified in accordance with ISO 14971:2007.
- Design Verification: The design output fulfills all design input requirements.
No clinical testing has been conducted.
Key results: The conclusion drawn from the non-clinical tests demonstrates that the subject device, the Anatase Spine Surgery Navigation System, Model number: SNS-Spine2-S, SNS-Spine2-V, is as safe, as effective, and performs as well as or better than the legally marketed predicate device cleared under K180523.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
K162309 StealthstationS8 System Platforms, K172548 Wiltrom Spinal Fixation System, K132884 PATHFINDER NXT MINIMALLY INVASIVE PEDICLE SCREW SYSTEM, K113529 CD HORIZON VOYAGER SPINAL SYSTEM, K150231 Navigated Disc Prep Instruments
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.4560 Stereotaxic instrument.
(a)
Identification. A stereotaxic instrument is a device consisting of a rigid frame with a calibrated guide mechanism for precisely positioning probes or other devices within a patient's brain, spinal cord, or other part of the nervous system.(b)
Classification. Class II (performance standards).
0
August 24, 2022
Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health and Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath.
Remex Medical Corporation % Sandy Liu Consultant Jin Services Co. 9F-1, No13, Lane41, Zhangrong Rd, Sec. 5, North District Tainan City, 70447 Taiwan
Re: K220348
Trade/Device Name: Anatase Spine Surgery Navigation System, Model number: SNS-Spine2-S and SNS-spine2-V Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic instrument Regulatory Class: Class II Product Code: OLO
Dear Sandy Liu:
The Food and Drug Administration (FDA) is sending this letter to notify you of an administrative change related to your previous substantial equivalence (SE) determination letter dated July 14, 2022. Specifically, FDA is updating this SE Letter for a typo in the company name as an administrative correction.
Please note that the 510(k) submission was not re-reviewed. For questions regarding this letter please contact Shumaya Ali, M.P.H., OHT6: Office of Orthopedic Devices, 301-796-2356, Shumaya.Ali(@fda.hhs.gov.
Sincerely,
Shumaya Ali-S
Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
1
July 14, 2022
Image /page/1/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The FDA logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA wordmark on the right. The Department of Health and Human Services logo is a stylized depiction of a human figure embracing a sphere. The FDA wordmark is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.
Remax Medical Corporation % Sandy Liu Consultant Jin Services Co. 9F-1. No13. Lane41. Zhangrong Rd. Sec. 5. North District Tainan City, 70447 Taiwan
Re: K220348
Trade/Device Name: Anatase Spine Surgery Navigation System, Model number: SNS-Spine2-S and SNS-spine2-V Regulation Number: 21 CFR 882.4560 Regulation Name: Stereotaxic Instrument Regulatory Class: Class II Product Code: OLO Dated: June 13, 2022 Received: June 13, 2022
Dear Sandy Liu:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
2
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for
combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE(@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Shumaya Ali-S
Shumaya Ali, M.P.H. Assistant Director DHT6C: Division of Restorative, Repair and Trauma Devices OHT6: Office of Orthopedic Devices Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
3
Indications for Use
510(k) Number (if known) K220348
Device Name
Anatase Spine Surgery Navigation System, Model number: SNS-Spine2-S and SNS-spine2-V
Indications for Use (Describe)
The Anatase Spine Surgery Navigation System is indicated for precise positioning of surgical instruments or spinal implants during general spinal surgery when reference to a rigid anatomical structure, such as the vertebra, can be identified relative to a patient's fluoroscopic or CT imagery. It is intended as a planning and intraoperative guidance system to enable open or percutaneous image guided surgery by means of registering intraoperative 2D fluoroscopic projections to pre-operative 3D CT imagery.
Example procedures include but are not limited to:
Posterior-approach spinal implant procedures, such as pedicle screw placement, within the lumbar region.
Type of Use (Select one or both, as applicable)> Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(k) Summary
As required by 21CFR 807.92
Applicant Information
| Company Name: | REMEX MEDICAL CORP. |
|---|---|
| Company Address: | 4F., No. 9, Jingke Road, Nantun Dist. Taichung, TW 408224, 408224, Taiwan |
| Telephone: | +886-4-23595336 |
| Fax: | +886-4-23598875 |
| Contact Person: | Shih-Chang Chuang |
| Summary Updated Date: | June 9, 2022 |
Official Correspondent
| Company Name: | Jin Services Co. |
|---|---|
| Company Address: | 9F-1, No13, Lane41, Zhangrong Rd, Sec. 5, North Distrit, Tainan City |
| 70447 Taiwan | |
| Telephone: | +886-917535026 |
| Email: | contact@fdaclass.com |
| Contact Person: | Sandy Liu, Consultant |
Device Name:
| Trade Name: | Anatase Spine Surgery Navigation System, Model number: SNS-Spine2-S
and SNS-spine2-V |
|----------------------|-----------------------------------------------------------------------------------------|
| Classification Name: | Stereotaxic instrument |
| Regulation Number: | 882.4560 |
| Product Code: | OLO |
| Device Class: | Class 2 |
| Panel: | Stereotaxic, Trauma and Restorative Devices (DHT6C) |
PREDICATE DEVICE:
K180523, INTAI Surgery Navigation System, Intai Technology Corporation
5
REFERENCE DEVICE:
K162309 StealthstationS8 System Platforms K172548 Wiltrom Spinal Fixation System K132884 PATHFINDER NXT MINIMALLY INVASIVE PEDICLE SCREW SYSTEM K113529 CD HORIZON VOYAGER SPINAL SYSTEM K150231 Navigated Disc Prep Instruments
Purpose of Submission: The purpose of this submission is to 1). The Optical Tracker camera "Polaris Spectra" has been discontinued by the supplier, NDI. We add the optional camera "Polaris Vega" to ensure continuous supply of products after clearing the stock of "Polaris Spectra". 2) The calibration process of navigation before surgery become to utilize smoothly via modification of calibration software module and changing the design of calibration instruments. 3) The additional specific screwdrivers are for use with more brands of pedical screws, specifically, Wiltrom™ Spinal Fixation System, PATHFINDER NXT™ Minimally Invasive Pedicle Screw System, and CD HORIZON SOLERA VOYAGER 4.75 SPINAL SYSTEM™. 4) The original trade name "INTAI Surgery Navigation System" was changed after design modification and rename to "Anatase Spine Surgery Navigation System".
Device Description
The Anatase Spine Surgery Navigation System, also known as an Image Guided System, is comprised of a platform, clinical software, surgical instruments, and a referencing system. The system uses optical tracking technology to track the position of instruments in relation to the surgical anatomy and identifies this position on diagnostic or intraoperative images of a patient. The system helps guide surgeons during spine procedures such as spinal fusion. The software functionality in terms of its feature sets is categorized as imaging modalities, registration, planning, interfaces with medical devices, and views.
The modified Anatase Spine Surgery Navigation System, the subject of these 510(k) applications, introduces software, hardware and instruments modifications to the original Surgery Navigation System cleared in 510(k) K180523.
Intended Use:
The Anatase Spine Surgery Navigation System, Model number: SNS-spine2-S and SNS-spine2-V is indicated for precise positioning of surgical instruments or spinal implants during general spinal surgery when reference to a rigid anatomical structure, such as the vertebra, can be identified relative to a patient's fluoroscopic or CT imagery. It is intended as a planning and intraoperative guidance
6
system to enable open or percutaneous image guided surgery by means of registering intraoperative 2D fluoroscopic projections to pre-operative 3D CT imagery. Example procedures include but are not limited to: Posterior-approach spinal implant procedures, such as pedicle screw placement, within the lumbar region.
Substantial Equivalence Comparison
The subject device has the same intended use and technological characteristics as the predicate device. Below is a comparison of the indications for use and technological characteristics of subject device to the predicate device and an assessment of the equivalence of each characteristic.
| Items | Subject Device | Predicate Device | Comparison Result |
|---|---|---|---|
| Anatase Spine Surgery Navigation System, Model number: SNS-Spine2-S, SNS-Spine2-V | INTAI Surgery Navigation System | ||
| Submitter | REMEX MEDICAL CORP. | Intai Technology Corporation | N/A |
| Trade name | Anatase Spine Surgery Navigation System | INTAI Surgery Navigation System | N/A |
| Model number | SNS-Spine2-S | ||
| SNS-Spine2-V | SNS-Spine | Note 1 | |
| 510(k) Number | N/A | K180523 | N/A |
| Device Regulation number | 882.4560 | 882.4560 | same |
| Classification | 2 | 2 | same |
| FDA Product Code | OLO | OLO | same |
| Indications for Use | The Anatase Spine Surgery Navigation System, Model number: SNS-Spine2-S, SNS-Spine2-V SNS-spine2-S and SNS-spine2-V is indicated for precise positioning of surgical instruments or spinal implants during general spinal surgery when reference to a rigid anatomical structure, such as the vertebra, can be identified relative to a patient's fluoroscopic or CT imagery. It is intended as a planning and intraoperative guidance system to enable open or percutaneous image guided surgery by means of registering intraoperative 2D fluoroscopic projections to pre-operative 3D CT imagery.Example procedures | The Intai Technology Corporation is indicated for precise positioning of surgical instruments or spinal implants during general spinal surgery when reference to a rigid anatomical structure, such as the vertebra, can be identified relative to a patient's fluoroscopic or CT imagery. It is intended as a planning and intraoperative guidance system to enable open or percutaneous image guided surgery by means of registering intraoperative 2D fluoroscopic projections to pre-operative 3D CT imagery.Example procedures include but are not limited to: | Same |
| Items | Subject Device | Predicate Device | Comparison |
| Result | |||
| Anatase Spine Surgery | |||
| Navigation System, Model | |||
| number: SNS-Spine2-S, | |||
| SNS-Spine2-V | INTAI Surgery Navigation | ||
| System | |||
| include but are not limited to: | |||
| Posterior-approach spinal implant | |||
| procedures, such as pedicle screw | |||
| placement, within the lumbar | |||
| region. | Posterior-approach spinal | ||
| implant procedures, such as | |||
| pedicle screw placement, within | |||
| the lumbar region. | |||
| Operating | |||
| principle | The subject device creates a | ||
| relative position between the | |||
| patient and 2D C-arm images by | |||
| means of capturing intra-operative | |||
| 2D C-arm images of the patient. | |||
| The relative position between the | |||
| patient and 3D CT images is | |||
| established through the registration | |||
| of intra-operative 2D C-arm | |||
| images to pre-operative 3D CT | |||
| images. Subsequently, the subject | |||
| device can continuously display | |||
| the relative position of a tracked | |||
| instrument to a representation of | |||
| the patient's anatomy. The surgeon | |||
| can utilize this information as a | |||
| guide to perform either open or | |||
| percutaneous spine surgery. | The subject device creates a | ||
| relative position between the | |||
| patient and 2D C-arm images by | |||
| means of capturing intra- | |||
| operative 2D C-arm images of | |||
| the patient. The relative position | |||
| between the patient and 3D CT | |||
| images is established through | |||
| the registration of intra- | |||
| operative 2D C-arm images to | |||
| pre-operative 3D CT images. | |||
| Subsequently, the subject device | |||
| can continuously display the | |||
| relative position of a tracked | |||
| instrument to a representation of | |||
| the patient's anatomy. The | |||
| surgeon can utilize this | |||
| information as a guide to | |||
| perform either open or | |||
| percutaneous spine surgery. | Same | ||
| Supported | |||
| image format | DICOM | DICOM | Same |
| Prescription | |||
| for use | Yes | Yes | Same |
| Over the | |||
| Counter | No | No | Same |
| Contain any | |||
| drugs or | |||
| biologics | No | No | Same |
| Contain | |||
| LATEX | Yes | Yes | Same |
| REUSE | Yes | Yes | Same |
| Non-Sterile | |||
| devices | |||
| provided | Yes | Yes | Same |
| Operating | |||
| temperature | 10°C - 40°C | 10°C - 40°C | Same |
| Operating | |||
| humidity | 30-75% (RH) | 30-75% (RH) | Same |
| Operating | |||
| pressure | 700hPa-1060 hPa | 700hPa-1060 hPa | same |
| Storage | -10°C - 50°C | -10°C - 50°C | same |
| Items | Subject Device | Predicate Device | Comparison Result |
| Anatase Spine Surgery | |||
| Navigation System, Model | |||
| number: SNS-Spine2-S, | |||
| SNS-Spine2-V | INTAI Surgery Navigation | ||
| System | |||
| temperature | |||
| Storage | |||
| humidity | 10-90% (RH) | 10-90% (RH) | same |
| Storage | |||
| pressure | 700 hPa-1060 hPa | 700 hPa-1060 hPa | same |
| Transport | |||
| temperature | -10°C - 50°C | -10°C - 50°C | same |
| Transport | |||
| humidity | 10-90% (RH) | 10-90% (RH) | same |
| Transport | |||
| pressure | 700 hPa-1060 hPa | 700 hPa-1060 hPa | same |
| Main system | |||
| components | ● Navigation cart, including | ||
| optical tracker, No touch | |||
| reader, medical panel PC and | |||
| articulating arms | |||
| ● Image Calibrator with | |||
| Assembly Kit | |||
| ● Instrument kits | |||
| ● Navigation software | |||
| installation Disc | |||
| ● User Manual and Software | |||
| Installation Manual | ● Navigation cart, including | ||
| optical tracker, No touch | |||
| reader, medical panel PC | |||
| and articulating arms | |||
| ● Image Calibrator with | |||
| Assembly Kit | |||
| ● Instrument kits | |||
| ● Navigation software | |||
| installation Disc | |||
| ● User Manual and | |||
| Software Installation | |||
| Manual | same |
7
8
*Note 1: The Optical Tracker camera "Polaris Spectra" has been discontinued by the supplier, NDI. We add the optional Tracker camera "Polaris Vega" to ensure continuous supply of products after clearing the stock of "Polaris Spectra". To identify the different Optical Tracker camera for use in same navigation system, two (2) model numbers are created in the subject devices. "Polaris Vega" is current popular use in similar navigation system, such as reference device "K162309 StealthstationS8 System Platforms".
Therefore, it is concluded that the subject device (modified from predicate devices) is substantially equivalent to the predicate device with respect to its indications for use and technological characteristics.
Summary of Non-Clinical Testing
Verification and validation activities have been completed to provide sufficient assurance that the subject device meets the performance requirements under its indications for use conditions. Below is a summary of all performance tests carried out on the subject device. It is demonstrated that the subject device performs as safely and effectively as the predicate device.
9
| Test | Description |
|---|---|
| Sterilization | Moist heat sterilization of those reusable accessories is validated |
| in accordance with ISO 17665-1:2006. | |
| Repeated | |
| Reprocessing | Reliability of those reusable instruments after repeated |
| reprocessing is validated throughout their use-life, for reference | |
| of ISO 11737-2: 2019 | |
| Biocompatibility | Biocompatibility of those accessories that come into contact |
| with patient is evaluated in accordance with FDA guidance for | |
| the use of international standard ISO 10993-1, "Biological | |
| evaluation of medical devices – Part 1: Evaluation and testing | |
| within a risk management process" issued on June 16, 2016 and | |
| ISO 10993-1:2009. | |
| Software | Software is verified and validated in accordance with FDA |
| guidance for the content of premarket submissions for software | |
| contained in medical devices issued on May 11, 2005, | |
| Electrical Safety | Electrical safety of the system is complied with the requirements |
| of ANSI/AAMI ES60601-1:2005/(R)2012 and A1:2012, | |
| C1:2009/(R)2012 and A2:2010/(R)2012. | |
| Electromagnetic | |
| Compatibility | Electromagnetic compatibility of the system is complied with |
| the requirements of IEC 60601-1-2:2014. | |
| Usability | Usability of the system is validated in accordance with |
| ANSI/AAMI HE75:2009/(R)2013, IEC 62366-1:2015 and IEC | |
| 60601-1-6:2010 + A1:2013. | |
| Accuracy | Positional accuracy of the system is evaluated in accordance |
| with ASTM F2554-18. | |
| Risk Assessment | The effectiveness of all risk control measures is verified in |
| accordance with ISO 14971:2007. | |
| Design | |
| Verification | The design output fulfills all design input requirements. |
Clinical testing:
No clinical testing has been conducted.
Conclusions:
The conclusion drawn from the non-clinical tests demonstrates that the subject device, the Anatase Spine Surgery Navigation System, Model number: SNS-Spine2-S, SNS-Spine2-V, is as safe, as effective, and performs as well as or better than the legally marketed predicate device cleared under K180523. Thus, Anatase Spine Surgery Navigation System, Model number: SNS-Spine2-S, SNS-Spine2-V is substantially equivalent to the predicate devices with respect to its intended use, technological characteristics and performance characteristics.
Page 6 of 6